Shihong Wu
Union Hospital
Wuhan, 430022, China
Wuhan, 430022, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Correction: Combination chemotherapy of valproic acid (VPA) and gemcitabine regulates STAT3/Bmi1 pathway to differentially potentiate the motility of pancreatic cancer cells.
Journal: Cell & bioscience
Published: October 26, 2023
BRD9-SMAD2/3 orchestrates stemness and tumorigenesis in pancreatic ductal adenocarcinoma.
Journal: bioRxiv : the preprint server for biology
Published: March 13, 2023
High glucose-upregulated PD-L1 expression through RAS signaling-driven downregulation of PTRH1 leads to suppression of T cell cytotoxic function in tumor environment.
Journal: Journal of translational medicine
Published: December 09, 2022
Hyperglycemia Enhances Immunosuppression and Aerobic Glycolysis of Pancreatic Cancer Through Upregulating Bmi1-UPF1-HK2 Pathway.
Journal: Cellular and molecular gastroenterology and hepatology
Published: March 09, 2022
A novel staging system and clinical predictive nomogram for more accurate staging and prognosis of malignant pancreatic intraductal papillary mucinous neoplasms: a population-based study.
Journal: Journal of translational medicine
Published: December 05, 2020
Overexpression of YBX1 Promotes Pancreatic Ductal Adenocarcinoma Growth via the GSK3B/Cyclin D1/Cyclin E1 Pathway.
Journal: Molecular therapy oncolytics
Published: February 09, 2020
A Population-Based Study of the Incidence and Survival of Anorectal Gastrointestinal Stromal Tumor.
Journal: Medical science monitor : international medical journal of experimental and clinical research
Published: July 22, 2019
ROS/KRAS/AMPK Signaling Contributes to Gemcitabine-Induced Stem-like Cell Properties in Pancreatic Cancer.
Journal: Molecular therapy oncolytics
Published: June 22, 2019
Combination chemotherapy of valproic acid (VPA) and gemcitabine regulates STAT3/Bmi1 pathway to differentially potentiate the motility of pancreatic cancer cells.
Journal: Cell & bioscience
Published: March 12, 2019
Tumor location as an indicator of survival in T1 resectable pancreatic ductal adenocarcinoma: a propensity score-matched analysis.
Journal: BMC gastroenterology
Published: February 14, 2019
High glucose promotes pancreatic cancer cells to escape from immune surveillance via AMPK-Bmi1-GATA2-MICA/B pathway.
Journal: Journal of experimental & clinical cancer research : CR
Published: December 27, 2018
Last Updated: 09/26/2026